October 8th 2025
The addition of Evo’s cryogenic shipping and tracking technology enhances Peli BioThermal’s reach across the pharma value chain, driving innovation and integration in temperature-controlled logistics while supporting these therapies.
GSK Commits $30B to Strengthen US Biopharma R&D and Manufacturing Capacity
September 18th 2025The pharmaceutical giant’s commitment includes a $1.2 billion investment in advanced facilities powered by AI and digital technology, strengthening biopharma manufacturing and clinical research across the United States.
Eli Lilly to Build $5 Billion Manufacturing Plant in Virginia, Expanding US Biopharma Capacity
September 17th 2025The new Goochland County facility will serve as Lilly’s first fully integrated API and drug product site, focusing on antibody-drug conjugates, while creating thousands of jobs and strengthening domestic supply chains.
DHL Supply Chain Acquires SDS Rx, Expanding Last-Mile Healthcare Logistics
September 12th 2025The deal will integrate SDS Rx’s specialized delivery network of US locations into DHL’s Life Sciences & Healthcare division, strengthening same-day and final-mile services as demand for specialty pharma and patient-centered logistics continues to rise.
Precision Dosing as a Market Strategy: How Model-Informed Tools Drive Cost, Speed and Access
September 8th 2025By reducing waste, improving forecasting, and strengthening payer negotiations, these technologies are helping pharmaceutical companies unlock efficiency, accelerate adoption, and differentiate in competitive markets.
Trump Pushes Supreme Court to Save Tariffs After Appeals Court Ruling Limits Presidential Power
September 4th 2025Following a federal appeals court decision that struck down much of his tariff authority under the International Emergency Economic Powers Act, President Trump is asking the Supreme Court to fast-track review.
Amgen to Invest $600M in New Science and Innovation Center at California HQ
September 3rd 2025The company is committing over half a billion dollars to build a state-of-the-art research hub in Thousand Oaks, CA, designed to accelerate next-generation therapeutics through advanced automation and collaboration.
EVERSANA, Waltz Health Form Combined Platform to Tackle Drug Costs and Access Challenges
August 27th 2025The merger integrates EVERSANA’s commercialization services with Waltz Health’s AI-powered payer tools to address patient affordability, streamline drug access, and reduce costs for high-expense therapies such as GLP-1s.
Genentech Breaks Ground on $700M North Carolina Manufacturing Facility
August 26th 2025The new 700,000-square-foot Holly Springs site—part of Roche’s $50 billion US investment plan—will focus on metabolic and obesity treatments, create 400 jobs, and strengthen domestic biopharma manufacturing amid shifting tariff and drug pricing policies.